BIOTE CORP -A (BTMD) Stock Price, Forecast & Analysis
NASDAQ:BTMD • US0906831039
BTMD Key Statistics, Chart & Performance
The current stock price of BTMD is 2.11 USD. In the past month the price decreased by -7.86%. In the past year, price decreased by -53.01%.
BTMD Technical Analysis
BTMD Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BTMD. Both the profitability and the financial health of BTMD get a neutral evaluation. Nothing too spectacular is happening here.
BTMD Financial Highlights
Over the last trailing twelve months BTMD reported a non-GAAP Earnings per Share(EPS) of 0.87. The EPS increased by 190% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.72% | ||
| ROA | 25.87% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BTMD Forecast & Estimates
11 analysts have analysed BTMD and the average price target is 4.94 USD. This implies a price increase of 134.13% is expected in the next year compared to the current price of 2.11.
For the next year, analysts expect an EPS growth of 229.18% and a revenue growth -3.44% for BTMD
BTMD Ownership
BTMD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 30.49 | 964.817B | ||
| JNJ | JOHNSON & JOHNSON | 21.19 | 590.254B | ||
| MRK | MERCK & CO. INC. | 22.52 | 301.963B | ||
| PFE | PFIZER INC | 8.94 | 155.618B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.91 | 121.595B | ||
| ZTS | ZOETIS INC | 18.53 | 56.906B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.7 | 26.172B | ||
| VTRS | VIATRIS INC | 6.32 | 18.486B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.1 | 12.312B | ||
| AXSM | AXSOME THERAPEUTICS INC | 227.33 | 9.313B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BTMD
Company Profile
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 217 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Company Info
BIOTE CORP -A
1875 W. Walnut Hill Ln #100, Floor 5
Irving TEXAS US
Employees: 217
Phone: 19724869346
BIOTE CORP -A / BTMD FAQ
Can you describe the business of BIOTE CORP -A?
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 217 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Can you provide the latest stock price for BIOTE CORP -A?
The current stock price of BTMD is 2.11 USD. The price increased by 1.93% in the last trading session.
What is the dividend status of BIOTE CORP -A?
BTMD does not pay a dividend.
What is the ChartMill technical and fundamental rating of BTMD stock?
BTMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for BTMD stock?
11 analysts have analysed BTMD and the average price target is 4.94 USD. This implies a price increase of 134.13% is expected in the next year compared to the current price of 2.11.
What is the employee count for BTMD stock?
BIOTE CORP -A (BTMD) currently has 217 employees.
What is the next earnings date for BTMD stock?
BIOTE CORP -A (BTMD) will report earnings on 2026-03-10, after the market close.